The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review)
Open accessAbstract
Oxidative stress is increasingly recognized as a central event contributing to the degeneration of dopaminergic neurons in the pathogenesis of Parkinson's disease (PD). Although reactive oxygen species (ROS) production is implicated as a causative factor in PD, the cellular and molecular mechanisms linking oxidative stress with dopaminergic neuron death are complex and not well characterized. The primary insults cause the greatest production of ROS, which contributes to oxidative damage by attacking all macromolecules, including lipids, proteins and nucleic acids, leading to defects in their physiological function. Consequently, the defects in these macromolecules result in mitochondrial dysfunction and neuroinflammation, which subsequently enhance the production of ROS and ultimately neuronal damage. The interaction between these various mechanisms forms a positive feedback loop that drives the progressive loss of dopaminergic neurons in PD, and oxidative stress‑mediated neuron damage appears to serve a central role in the neurodegenerative process. Thus, understanding the cellular and molecular mechanisms by which oxidative stress contributes to the loss of dopaminergic neurons may provide a promising therapeutic approach in PD treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Self-citationChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Mitochondrial free radical generation, oxidative stress, and aging
Cadenas, E., & Davies, K. J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00317-8 · Cited by 3,010
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · cited 1×
“The dopaminergic neurons are particularly susceptible to microglia-mediated toxicity due to the highest density of microglial cells being distributed in the SN of the brain (121,122).”
BackgroundThe Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
PCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796 · cited 1×
“As a critical regulatory protein for DNA repair, proliferating cell nuclear antigen (PCNA) serves a central role in the repair of damaged DNA in a variety of pathological conditions via the interaction with numerous enzymes and regulatory proteins (135,136).”
BackgroundMultiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,517
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
The mitochondrial calcium uniporter is a highly selective ion channel
Kirichok, Y., Krapivinsky, G., & Clapham, D. E. (2004) · Nature · doi:10.1038/nature02246 · Cited by 1,409
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Oxidative DNA damage and disease: induction, repair and significance
Evans, M. D., Dizdaroglu, M., & Cooke, M. S. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.11.001 · Cited by 1,372 · cited 2×
“These studies demonstrate that dopaminergic neuron injury could be ascribed to the oxidative damage of nuclear DNA and mtDNA, which alters its coding properties or interferes with normal metabolic function, and subsequently results in cell death (128).”
BackgroundThe role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355
Mitochondrial metabolism of reactive oxygen species
Andreyev, A. Y., Kushnareva, Y. E., & Starkov, A. A. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0102-7 · Cited by 1,336
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
Chiba, K., Trevor, A., & Castagnoli, N. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91293-2 · Cited by 1,097
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 1×
“Microglia activation promotes the production of proinflammatory cytokines, which cause dopaminergic nigrostriatal neuron degeneration in MPTP models of PD (123).”
BackgroundMogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 887
Kim, W.-G., Mohney, R. P., Wilson, B., Jeohn, G.-H., Liu, B., & Hong, J.-S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 878
The role of mitochondria in reactive oxygen species metabolism and signaling
Starkov, A. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.015 · Cited by 846 · cited 1×
“Mitochondria are the primary intracellular source of ROS, and for this reason the organelles are frequently exposed to oxidative stress (51,52).”
BackgroundAlam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845 · cited 1×
“In PD, increased levels of 8-hydroxyguanine, the marker of DNA oxidative damage, have been detected selectively in the SN (7,129).”
BackgroundWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Mitochondria, oxidative stress and neurodegeneration
Federico, A., Cardaioli, E., Da Pozzo, P., Formichi, P., Gallus, G. N., & Radi, E. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.030 · Cited by 787
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 739
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Kussmaul, L., & Hirst, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510977103 · Cited by 720
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682
Neuroinflammation in Parkinson's disease
Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 657
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Ekstrand, M. I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F. S., Trifunovic, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605208103 · Cited by 605 · cited 1×
“Inhibition of mtDNA expression leads to dysfunction in the respiratory chain in dopaminergic neurons accompanied by progressive parkinsonism in mouse models (59).”
BackgroundTargeting programmed cell death in neurodegenerative diseases
Vila, M., & Przedborski, S. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1100 · Cited by 546
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Characterization of Superoxide-producing Sites in Isolated Brain Mitochondria
Kudin, A. P., Bimpong-Buta, N. Y.-B., Vielhaber, S., Elger, C. E., & Kunz, W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310341200 · Cited by 508
Halestrap, A., & Brenner, C. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457278 · Cited by 503
Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?
Candé, C., Cecconi, F., Dessen, P., & Kroemer, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00210 · Cited by 491
Floor, E., & Wetzel, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010268.x · Cited by 452
The Role of Glial Reaction and Inflammation in Parkinson's Disease
HIRSCH, E. C., BREIDERT, T., ROUSSELET, E., HUNOT, S., HARTMANN, A., & MICHEL, P. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07478.x · Cited by 449
Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435
The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA
Wilson, D. M., & Barsky, D. (2001) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(01)00063-5 · Cited by 408
Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study
Dexter, D. T., Holley, A. E., Flitter, W. D., Slater, T. F., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P., & Marsden, C. D. (1994) · Movement Disorders · doi:10.1002/mds.870090115 · Cited by 407
An Involvement of Oxidative Stress in Endoplasmic Reticulum Stress and Its Associated Diseases
Bhandary, B., Marahatta, A., Kim, H.-R., & Chae, H.-J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010434 · Cited by 407
Herrera, A. J., Castaño, A., Venero, J. L., Cano, J., & Machado, A. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0289 · Cited by 392
Complex I deficiency in Parkinson's disease frontal cortex
Parker, W. D., Parks, J. K., & Swerdlow, R. H. (2008) · Brain Research · doi:10.1016/j.brainres.2007.10.061 · Cited by 382
Regulation of PCNA–protein interactions for genome stability
Mailand, N., Gibbs-Seymour, I., & Bekker-Jensen, S. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3562 · Cited by 377
Linseman, D. A., Butts, B. D., Precht, T. A., Phelps, R. A., Le, S. S., Laessig, T. A., Bouchard, R. J., Florez-McClure, M. L., & Heidenreich, K. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2057-04.2004 · Cited by 370
Gao, H.-M., Zhou, H., Zhang, F., Wilson, B. C., Kam, W., & Hong, J.-S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3732-10.2011 · Cited by 369
Platelet mitochondria function in Parkinson's disease
Krige, D., Carroll, M. T., Cooper, J. M., Marsden, C. D., Schapira, A. H. V., & (The Royal Kings Queens Parkinson Disease Research Group) (1992) · Annals of Neurology · doi:10.1002/ana.410320612 · Cited by 352
The relevance of iron in the pathogenesis of Parkinson’s disease
Sian‐Hülsmann, J., Mandel, S., Youdim, M. B. H., & Riederer, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07132.x · Cited by 352
Ceulemans, A.-G., Zgavc, T., Kooijman, R., Hachimi-Idrissi, S., Sarre, S., & Michotte, Y. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-74 · Cited by 351
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Sanders, L. H., & Timothy Greenamyre, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.003 · Cited by 345
Neuroinflammation: Modulation by flavonoids and mechanisms of action
Spencer, J. P. E., Vafeiadou, K., Williams, R. J., & Vauzour, D. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.016 · Cited by 315
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage
Perier, C., Tieu, K., Guégan, C., Caspersen, C., Jackson-Lewis, V., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., & Vila, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508215102 · Cited by 308
Oxidative Stress in Neurodegeneration
Shukla, V., Mishra, S. K., & Pant, H. C. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/572634 · Cited by 288
Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy
Qian, L., Flood, P. M., & Hong, J.-S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0428-1 · Cited by 287
Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Kockeritz, L., Doble, B., Patel, S., & Woodgett, J. (2006) · Current Drug Targets · doi:10.2174/1389450110607011377 · Cited by 284
Kohutnicka, M., Lewandowska, E., Kurkowska-Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283
Członkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Neuroinflammation in Alzheimer’s disease
Zhang, F., & Jiang, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75546 · Cited by 276
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease
Hattori, N., Tanaka, M., Ozawa, T., & Mizuno, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410300409 · Cited by 276
Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53
Watcharasit, P., Bijur, G. N., Song, L., Zhu, J., Chen, X., & Jope, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305870200 · Cited by 262
Mitochondrial Transporters as Novel Targets for Intracellular Calcium Signaling
Satrústegui, J., Pardo, B., & del Arco, A. (2007) · Physiological Reviews · doi:10.1152/physrev.00005.2006 · Cited by 256
Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection
Wen, Y., Li, W., Poteet, E. C., Xie, L., Tan, C., Yan, L.-J., Ju, X., Liu, R., Qian, H., Marvin, M. A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208447 · Cited by 251
Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases
A. Frankola, K., H. Greig, N., Luo, W., & Tweedie, D. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794653751 · Cited by 251
Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases
Montine, K. S., Quinn, J. F., Zhang, J., Fessel, J. P., Roberts, L. J., Morrow, J. D., & Montine, T. J. (2004) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.10.010 · Cited by 243
Sriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242
Nishihara, M., Miura, T., Miki, T., Tanno, M., Yano, T., Naitoh, K., Ohori, K., Hotta, H., Terashima, Y., & Shimamoto, K. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.010 · Cited by 235
Alpha-synuclein, lipids and Parkinson’s disease
Ruipérez, V., Darios, F., & Davletov, B. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.05.004 · Cited by 231
Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase
Chéret, C., Gervais, A., Lelli, A., Colin, C., Amar, L., Ravassard, P., Mallet, J., Cumano, A., Krause, K.-H., & Mallat, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3568-08.2008 · Cited by 225
Liu, W., Kato, M., Akhand, A. A., Hayakawa, A., Suzuki, H., Miyata, T., Kurokawa, K., Hotta, Y., Ishikawa, N., & Nakashima, I. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.4.635 · Cited by 217
Rush, J. D., & Koppenol, W. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62677-3 · Cited by 200
Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease
Yoshino, H., Nakagawa-Hattori, Y., Kondo, T., & Mizuno, Y. (1992) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02257619 · Cited by 195
Potential Therapeutic Benefits of Strategies Directed to Mitochondria
Camara, A. K. S., Lesnefsky, E. J., & Stowe, D. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2788 · Cited by 194
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
Sanders, L. H., McCoy, J., Hu, X., Mastroberardino, P. G., Dickinson, B. C., Chang, C. J., Chu, C. T., Van Houten, B., & Greenamyre, J. T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.014 · Cited by 191
Neuronal vulnerability, pathogenesis, and Parkinson's disease
Sulzer, D., & Surmeier, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25187 · Cited by 184
Blin, O., Desnuelle, C., Rascol, O., Borg, M., Paul, H. P. S., Azulay, J. P., Billé, F., Figarella, D., Coulom, F., Pellissier, J. F., et al. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90248-8 · Cited by 182
King, T. D., Bijur, G. N., & Jope, R. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03005-0 · Cited by 177
Neuroinflammation in Huntington’s disease
Möller, T. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0430-7 · Cited by 177
Biology of Mitochondria in Neurodegenerative Diseases
Martin, L. J. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00005-9 · Cited by 163
Mitochondrial respiratory chain dysfunction: Implications in neurodegeneration
Morán, M., Moreno-Lastres, D., Marín-Buera, L., Arenas, J., Martín, M. A., & Ugalde, C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.009 · Cited by 163
A CaPful of mechanisms regulating the mitochondrial permeability transition
Lisa, F. D., & Bernardi, P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.03.006 · Cited by 163
Oxidative Stress and Microglial Cells in Parkinson's Disease
Peterson, L. J., & Flood, P. M. (2012) · Mediators of Inflammation · doi:10.1155/2012/401264 · Cited by 161
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice
Lan, J., & Jiang, D. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277665 · Cited by 159
Inhibition of glycogen synthase kinase-3β protects dopaminergic neurons from MPTP toxicity
Wang, W., Yang, Y., Ying, C., Li, W., Ruan, H., Zhu, X., You, Y., Han, Y., Chen, R., Wang, Y., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.03.017 · Cited by 158
Lofrumento, D., Nicolardi, G., Cianciulli, A., Nuccio, F. D., Pesa, V. L., Carofiglio, V., Dragone, T., Calvello, R., & Panaro, M. (2014) · Innate Immunity · doi:10.1177/1753425913488429 · Cited by 153
Pathophysiological and protective roles of mitochondrial ion channels
O'Rourke, B. P. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00023.x · Cited by 146
The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
Surmeier, D. J., Guzmán, J. N., Sánchez-Padilla, J., & Goldberg, J. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3521 · Cited by 142
Isobe, C., Abe, T., & Terayama, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.065 · Cited by 139
Tan, J. Y., Zhuang, L., Leong, H. S., Iyer, N. G., Liu, E. T., & Yu, Q. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1226 · Cited by 139
Iravani, M. M., Leung, C. C. M., Sadeghian, M., Haddon, C. O., Rose, S., & Jenner, P. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04220.x · Cited by 135
MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease
Kosta, P., Argyropoulou, M. I., Markoula, S., & Konitsiotis, S. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0914-9 · Cited by 135
Clinical Implications of Mitochondrial Dysfunction
Muravchick, S., Levy, R. J., & Warltier, D. C. (2006) · Anesthesiology · doi:10.1097/00000542-200610000-00029 · Cited by 133
The rotenone model of Parkinson's disease
Perier, C., Bové, J., Vila, M., & Przedborski, S. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00144-9 · Cited by 131
Arraf, Z., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.005 · Cited by 126
Simvastatin Attenuates Oxidant-Induced Mitochondrial Dysfunction in Cardiac Myocytes
Jones, S. P., Teshima, Y., Akao, M., & Marbán, E. (2003) · Circulation Research · doi:10.1161/01.res.0000097262.21507.df · Cited by 124
Obame, F. N., Plin, C., Assaly, R., Zini, R., Dubois‐Randé, J., Berdeaux, A., & Morin, D. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138008 · Cited by 120
Petit-Paitel, A., Brau, F., Cazareth, J., & Chabry, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005491 · Cited by 117
Neuroinflammation in Alzheimer’s Disease: from Pathogenesis to a Therapeutic Target
Pimplikar, S. W. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0032-5 · Cited by 116
Sziráki, I., Mohanakumar, K. P., Rauhala, P. V., Kim, H. G., YEH, K., & Chiueh, C. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00660-x · Cited by 113
Theruvath, T. P., Zhong, Z., Pediaditakis, P., Ramshesh, V. K., Currin, R. T., Tikunov, A. P., Holmuhamedov, E., & Lemasters, J. J. (2007) · Hepatology · doi:10.1002/hep.21912 · Cited by 107
Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
Li, D., Liu, Z., Wei‐Chen, MIN-YAO, & Li, G. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2080 · Cited by 104
Self-citationManganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains
Callio, J., Oury, T. D., & Chu, C. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413224200 · Cited by 104
Zhang, F., Li, Q., Flood, P. M., Shi, J., Hong, J., & Gao, H. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165829 · Cited by 100
Schmidt, H., Grune, T., Müller, R. H., Siems, W. G., & Wauer, R. R. (1996) · Pediatric Research · doi:10.1203/00006450-199607000-00003 · Cited by 99
Nitric oxide and calcium together inactivate mitochondrial complex I and induce cytochrome c release
Jekabsone, A., Ivanovienė, L., Brown, G. C., & Borutaitė, V. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00137-8 · Cited by 96
Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease
Mytilineou, C., Werner, P., Molinari, S., Rocco, A. D., Cohen, G., & Yahr, M. D. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260943 · Cited by 92
The destiny of Ca2+ released by mitochondria
Takeuchi, A., Kim, B., & Matsuoka, S. (2014) · The Journal of Physiological Sciences · doi:10.1007/s12576-014-0326-7 · Cited by 87
Studies on genomic DNA topology and stability in brain regions of Parkinson’s disease
Hegde, M. L., Gupta, V. B., Anitha, M., Harikrishna, T., Shankar, S. K., Muthane, U. B., Rao, K. S. J., & Rao, K. S. J. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.02.018 · Cited by 83
Mitochondrial dysfunction in central nervous system white matter disorders
Morató, L., Bertini, E., Verrigni, D., Ardissone, A., Ruíz, M., Ferrer, I., Uziel, G., & Pujol, A. (2014) · Glia · doi:10.1002/glia.22670 · Cited by 81
Theruvath, T. P., Snoddy, M. C., Zhong, Z., & Lemasters, J. J. (2008) · Transplantation · doi:10.1097/tp.0b013e31816fefb5 · Cited by 80
Burkovics, P., Hajdú, I., Szukacsov, V., Unk, I., & Haracska, L. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp357 · Cited by 79
Kudin, A. P., Dębska–Vielhaber, G., & Kunz, W. S. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.03.012 · Cited by 76
Gutteridge, J. M. C. (1990) · Free Radical Research Communications · doi:10.3109/10715769009148579 · Cited by 71
Amoroso, A., Concia, L., Maggio, C., Raynaud, C., Bergounioux, C., Crespan, E., Cella, R., & Maga, G. (2011) · The Plant Cell · doi:10.1105/tpc.110.081455 · Cited by 62
Mir, M., Tolosa, L., Asensio, V. J., Lladó, J., & Olmos, G. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.002 · Cited by 60
Unregulated mitochondrial GSK3β activity results in NADH:Ubiquinone oxidoreductase deficiency
King, T. D., Clodfelder‐Miller, B., Barksdale, K. A., & Bijur, G. N. (2008) · Neurotoxicity Research · doi:10.1007/bf03033861 · Cited by 57
Mitochondrial base excision repair assays
Maynard, S., de Souza-Pinto, N. C., Scheibye‐Knudsen, M., & Bohr, V. A. (2010) · Methods · doi:10.1016/j.ymeth.2010.02.020 · Cited by 55
DNA Repair Genes in Parkinson's Disease
Gençer, M., Daşdemir, S., Çakmakoğlu, B., Çetinkaya, Y., Varlıbaş, F., Tireli, H., Küçükali, C. İ., Özkök, E., & Aydın, M. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0252 · Cited by 53
Iravani, M. M., Sadeghian, M., Leung, C. C. M., Jenner, P. G., & Rose, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.01.022 · Cited by 53
Elstner, M., Müller, S. K., Leidolt, L., Laub, C., Krieg, L., Schlaudraff, F., Liss, B., Morris, C. M., Turnbull, D. M., Masliah, E., et al. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-43 · Cited by 50
Jo, H., Noma, A., & Matsuoka, S. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.12.012 · Cited by 50
Repair and mutagenesis at oxidized DNA lesions in the developing brain of wild-type and Ogg1−/− mice
Larsen, E., Reite, K., Nesse, G., Gran, C., Seeberg, E. C., & Klungland, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209284 · Cited by 49
Li, D., Guang-ren, L., Zhang, B., FENG, J.-J., & Zhao, H. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2430 · Cited by 36
Cited by
Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Sulaiman Rahman, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,149
Pisoschi, A. M., Pop, A., Iordache, F., Stanca, L., Predoi, G., & Serban, A. I. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112891 · Cited by 816
NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
Vermot, A., Petit-Härtlein, I., Smith, S. M. E., & Fieschi, F. (2021) · Antioxidants · doi:10.3390/antiox10060890 · Cited by 766
Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)
Zhao, Y., Zhang, X., Chen, X., & Wei, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5070 · Cited by 634
One-Carbon Metabolism: Pulling the Strings behind Aging and Neurodegeneration
Lionaki, E., Ploumi, C., & Tavernarakis, N. (2022) · Cells · doi:10.3390/cells11020214 · Cited by 110
Metadata
- Authors
- Guo, J., Zhao, X., Li, Y., Li, G., & Liu, X.
- Venue
- International Journal of Molecular Medicine
- Publisher
- Spandidos Publications
- Published
- 2018-01-19
- Volume
- 41
- Issue
- 4
- Pages
- 1817-1825
- ISSN
- 1107-3756 (ISSN-L)
- 1791-244X
- OpenAlex
- W2784858783
- Cited by
- 335
- References
- 137
- FWCI
- 18.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.